UARK 2014-08 A Phase II Open-Label, Multiple-Dose, Single Agent Study to Evaluate the Overall Response Rate of Orally Administered Trametinib
Clinical trial NCT02140840 · WITHDRAWN
Trial details
- NCT number
- NCT02140840
- Sponsor
- University of Arkansas
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2016-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.